Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001197032-26-000002

Options or other derivatives

  • Chief Executive Officer acquired 322,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SMITH IAN F Chief Executive Officer 2026-02-17 Grant or award · Employee Stock Option (Right to Buy) +193,000 193,000 D
SMITH IAN F Chief Executive Officer 2026-02-17 Grant or award · Restricted Stock Units +129,000 129,000 D
Loading xslF345X05/form4-02192026_090250.xml…